Search clinical trials for: Respiratory Syncytial Virus

Total 77157 results

Ablynx

Completed

ALX-0171 Safety Study in Adults With Hyperresponsive Airways

Respiratory Syncytial Virus Infection

Germany
Ablynx

Completed

ALX-0171 Phase I Pharmacokinetic Study in Healthy Male Volunteers

Healthy | RSV Infection

Belgium
Ablynx

Completed

ALX-0171 Phase I Study, Evaluating Single Ascending Dose and Multiple Dose in Healthy Male Volunteers

RSV Infection

Netherlands
GlaxoSmithKline

Completed

Safety, Reactogenicity and Immunogenicity Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals' Investigational RSV Vaccine (GSK3003891A), in Healthy Women

Respiratory Syncytial Virus Infections

United States, Australia, Germany, Czechia
Ark Biosciences Inc.

Terminated

A Study of AK0529 in Infants Hospitalized With RSV

Respiratory Syncytial Virus Infections

Australia
GlaxoSmithKline

Completed

Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A) in Healthy Women

Respiratory Syncytial Virus Infections

Belgium
Biota Scientific Management Pty Ltd

Completed

Safety Study of Oral BTA9881 to Treat RSV Infection

Respiratory Syncytial Virus Infections

Australia
Biota Pharmaceuticals, Inc.

Completed

Phase 1 Safety and Pharmacokinetics Study of Single Ascending Doses of BTA-C585 in Healthy Volunteers

Healthy Volunteers | Pharmacokinetics

United States
Biota Pharma Europe Limited

Completed

Safety, Efficacy and Pharmacokinetics of BTA-C585 in a RSV Viral Challenge Study

Respiratory Syncytial Virus (RSV) Infection

United Kingdom
Biota Pharmaceuticals, Inc.

Completed

Safety and Pharmacokinetics Study of Multiple Ascending Doses of BTA-C585 in Healthy Volunteers

Healthy Volunteers | Pharmacokinetics

United States
Pulmocide Ltd

Completed

A Study of PC786 to Evaluate the Antiviral Activity, Safety and Pharmacokinetics of Multiple Doses in an RSV Challenge Study

Respiratory Syncytial Virus Infections

United Kingdom
Sunnybrook Health Sciences Centre
Abbott

Completed

Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody Therapy

Respiratory Syncytial Virus Infections | Lower Respiratory Tract Infection

Canada
Fondation Ophtalmologique Adolphe de Rothschild

Terminated

Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE). (POMPRENELLE)

Parkinson's Disease

France
MedImmune LLC

Completed

A Study to Evaluate the Safety and Immunogenicity of MEDI7510 in Older Adults

Respiratory Syncytial Virus (RSV)

United States
AbbVie

Completed

A Study to Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and the Republic of Belarus (Synagis Russia)

Respiratory Syncytial Virus (RSV)
Danone Asia Pacific Holdings Pte, Ltd.

Terminated

Biomarkers in Saliva and Stool

Healthy

Singapore
Hamad Medical Corporation

Completed

"Palivizumab Therapy for RSV-bronchiolitis"

Respiratory Syncytial Virus-bronchiolitis

Qatar
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Infectivity, Safety, and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants and Children 6 to 24 Months of Age

Respiratory Syncytial Virus Infections

United States
Alnylam Pharmaceuticals

Completed

Phase 2b Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)

Respiratory Syncytial Virus Infections

United States, Australia, Austria, Canada, France, Germany
Alnylam Pharmaceuticals

Completed

Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)

Respiratory Syncytial Virus Infections

United States, Australia
Masonic Cancer Center, University of Minnesota

Completed

Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer

Sarcoma | Cervical Cancer | Ovarian Cancer | Fallopian Tube Cancer | Thromboembolism | Vulvar Cancer | Endometrial Cancer | Vaginal Cancer

United States
MedImmune LLC

Terminated

A Study to Evaluate the Efficacy of MEDI7510 in Older Adults

Respiratory Syncytial Virus

United States, Chile, South Africa, Canada, Estonia, Lithuania, Latvia
Pulmocide Ltd

Completed

A Study to Investigate the Safety and Tolerability of Single and Repeat Doses of PC786

Respiratory Syncytial Virus (RSV)

United Kingdom
Alios Biopharma Inc.

Completed

A Phase 1, Open-Label Study of the Absorption, Metabolism, Excretion and Absolute Bioavailability of ALS-008176

Respiratory Syncytial Virus Infections

United Kingdom
Alios Biopharma Inc.

Completed

Study of Single and Multiple Doses of ALS-008176 in Healthy Volunteers

Respiratory Syncytial Virus Infections

France
Alios Biopharma Inc.

Completed

A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus

Respiratory Syncytial Virus Infections

Australia, Singapore, United States, New Zealand, Taiwan
Valleywise Health

Completed

Aquacel Versus Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage

Abscess | Cellulitis

United States
Mucosis BV
Imperial College London

Unknown

Phase I Study for SynGEM, an Intranasal Respiratory Syncytial Virus (RSV) Prefusion F Subunit Candidate Vaccine (SynGEM)

Respiratory Syncytial Viral Infections

United Kingdom
MedImmune LLC

Terminated

Intranasal Challenge of Healthy Adults With Respiratory Syncytial Virus (RSV)

RSV Infection

United Kingdom
Washington University School of Medicine

Completed

Azithromycin to Prevent Wheezing Following Severe Respiratory Syncytial Virus (RSV) Bronchiolitis (APW-RSV)

RSV Bronchiolitis

United States
Wael Seliem

Completed

Effect of Heliox on RSV Bronchiolitis

RSV Infection | Acute Bronchiolitis
GlaxoSmithKline

Completed

Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccines

Infections, Respiratory Syncytial Virus

Canada
AstraZeneca

Completed

An Observational Study of Respiratory Syncytial Virus (RSV) Hospitalizations in Preterm Infants (SENTINEL1)

Respiratory Syncytial Virus Hospitalizations

United States
QIAGEN Gaithersburg, Inc

Completed

Collection and Testing of Respiratory Samples

Respiratory Syncytial Virus Infections | Influenza A | Rhinovirus | Influenza B | QIAGEN ResPlex II Advanced Panel | Infection Due to Human Parainfluenza Virus 1 | Parainfluenza Type 2 | Parainfluenza Type 3 | Parainfluenza Type 4 | Human Metapneumovirus A/B | Coxsackie Virus/Echovirus | Adenovirus Types B/C/E | Coronavirus Subtypes 229E and other conditions

United States
GlaxoSmithKline

Completed

Evaluation of Danirixin (GSK1325756) Inhibition of CD11b Cell Surface Expression

Infections, Respiratory Syncytial Virus

United States
University College, London
Public Health England

Completed

Specific Respiratory Infections as Triggers of Acute Medical Events

Cardiovascular Diseases | Influenza, Human | Respiratory Syncytial Virus Infections | Adenovirus | Rhinovirus | Parainfluenza | Human Metapneumovirus Pneumonia

United Kingdom
AbbVie

Completed

Synagis® Liquid 50mg, 100mg for Intramuscular Injection Special Investigation in Immunocompromised Children With Synagis®

Respiratory Syncytial Virus Infection
Dana-Farber Cancer Institute
Leadiant Biosciences, Inc.

Terminated

A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma

T-Cell Lymphoma | Relapsed T-Cell Lymphoma | Refractory T-Cell Lymphoma

United States
University Hospital, Toulouse
French Parkinson Association

Completed

Evaluation of the Role of the Noradrenergic System in Pain Perception in Parkinson's Disease (DOULOX)

Parkinson's Disease

France
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children

Respiratory Syncytial Virus Infections

United States
MedImmune LLC

Completed

A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI8897 in Healthy Adults

Respiratory Syncytial Virus Infections

United States
Janssen Pharmaceutica N.V., Belgium

Completed

Idylla IFV-RSV Panel Clinical Testing (RP1)

Respiratory Tract Infections | Influenza, Human | Respiratory Syncytial Virus Infections

United States
Imperial College London

Terminated

Studying Innate Immune Responses in Infants With Bronchiolitis

Bronchiolitis

United Kingdom
Crucell Holland BV

Completed

A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad26.RSV.FA2 Followed by Ad35.RSV.FA2 in Healthy Adult Volunteers

Respiratory Tract Infections | Respiratory Syncytial Viruses

United States
Universidad del Desarrollo
Hospital Padre Hurtado

Completed

Chest Physiotherapy in Infants Between 0 and 12 Months Old With Acute Bronchiolitis SRV(+)

Bronchiolitis, Viral

Chile
MedImmune LLC

Completed

A Study to Evaluate the Safety of the Respiratory Syncytial Virus Vaccine MEDI7510 in Older Adults

Respiratory Syncytial Virus (RSV)

United States
Janssen Research & Development, LLC

Completed

A Study in Belgian Children Hospitalized With Respiratory Syncytial Virus Related Acute Respiratory Infections

Respiratory Syncytial Virus

Belgium
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children

Respiratory Syncytial Virus Infections

United States
IQuum, Inc.
Roche Molecular Systems, Inc

Completed

Detection of Influenza A, Influenza B, and RSV Using the Liat™ Assays on the Liat™ Analyzer

Influenza A | Respiratory Syncytial Virus (RSV) | Influenza B

United States
Bavarian Nordic

Completed

Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Recombinant MVA BN® RSV Vaccine

Respiratory Syncytial Virus Infections

United States

Search clinical trials for: Respiratory Syncytial Virus

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations